373 related articles for article (PubMed ID: 21229614)
1. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
Politis M; Pavese N; Tai YF; Kiferle L; Mason SL; Brooks DJ; Tabrizi SJ; Barker RA; Piccini P
Hum Brain Mapp; 2011 Feb; 32(2):258-70. PubMed ID: 21229614
[TBL] [Abstract][Full Text] [Related]
2. Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.
Chen L; Hua J; Ross CA; Cai S; van Zijl PCM; Li X
J Neurosci Res; 2019 Apr; 97(4):467-479. PubMed ID: 30489648
[TBL] [Abstract][Full Text] [Related]
3. Defective emotion recognition in early HD is neuropsychologically and anatomically generic.
Henley SM; Wild EJ; Hobbs NZ; Warren JD; Frost C; Scahill RI; Ridgway GR; MacManus DG; Barker RA; Fox NC; Tabrizi SJ
Neuropsychologia; 2008; 46(8):2152-60. PubMed ID: 18407301
[TBL] [Abstract][Full Text] [Related]
4. Differential Changes in Functional Connectivity of Striatum-Prefrontal and Striatum-Motor Circuits in Premanifest Huntington's Disease.
Kronenbuerger M; Hua J; Bang JYA; Ultz KE; Miao X; Zhang X; Pekar JJ; van Zijl PCM; Duan W; Margolis RL; Ross CA
Neurodegener Dis; 2019; 19(2):78-87. PubMed ID: 31412344
[TBL] [Abstract][Full Text] [Related]
5. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
Unschuld PG; Edden RA; Carass A; Liu X; Shanahan M; Wang X; Oishi K; Brandt J; Bassett SS; Redgrave GW; Margolis RL; van Zijl PC; Barker PB; Ross CA
Mov Disord; 2012 Jun; 27(7):895-902. PubMed ID: 22649062
[TBL] [Abstract][Full Text] [Related]
6. Microglial activation correlates with severity in Huntington disease: a clinical and PET study.
Pavese N; Gerhard A; Tai YF; Ho AK; Turkheimer F; Barker RA; Brooks DJ; Piccini P
Neurology; 2006 Jun; 66(11):1638-43. PubMed ID: 16769933
[TBL] [Abstract][Full Text] [Related]
7. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
[TBL] [Abstract][Full Text] [Related]
8. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
[TBL] [Abstract][Full Text] [Related]
9. Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers.
Politis M; Lahiri N; Niccolini F; Su P; Wu K; Giannetti P; Scahill RI; Turkheimer FE; Tabrizi SJ; Piccini P
Neurobiol Dis; 2015 Nov; 83():115-21. PubMed ID: 26297319
[TBL] [Abstract][Full Text] [Related]
10. Reduced amygdala volumes are related to motor and cognitive signs in Huntington's disease: The IMAGE-HD study.
Ahveninen LM; Stout JC; Georgiou-Karistianis N; Lorenzetti V; Glikmann-Johnston Y
Neuroimage Clin; 2018; 18():881-887. PubMed ID: 29876272
[TBL] [Abstract][Full Text] [Related]
11. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
[TBL] [Abstract][Full Text] [Related]
12. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
[TBL] [Abstract][Full Text] [Related]
13. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease.
Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
Exp Neurol; 2008 Sep; 213(1):137-44. PubMed ID: 18588876
[TBL] [Abstract][Full Text] [Related]
14. Regional subcortical shape analysis in premanifest Huntington's disease.
Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
[TBL] [Abstract][Full Text] [Related]
15. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.
Henley SM; Wild EJ; Hobbs NZ; Scahill RI; Ridgway GR; Macmanus DG; Barker RA; Fox NC; Tabrizi SJ
J Neurol; 2009 Feb; 256(2):203-12. PubMed ID: 19266143
[TBL] [Abstract][Full Text] [Related]
16. Microglial activation in presymptomatic Huntington's disease gene carriers.
Tai YF; Pavese N; Gerhard A; Tabrizi SJ; Barker RA; Brooks DJ; Piccini P
Brain; 2007 Jul; 130(Pt 7):1759-66. PubMed ID: 17400599
[TBL] [Abstract][Full Text] [Related]
17. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
[TBL] [Abstract][Full Text] [Related]
18. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
[TBL] [Abstract][Full Text] [Related]
19. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
20. Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
Niccolini F; Haider S; Reis Marques T; Muhlert N; Tziortzi AC; Searle GE; Natesan S; Piccini P; Kapur S; Rabiner EA; Gunn RN; Tabrizi SJ; Politis M
Brain; 2015 Oct; 138(Pt 10):3016-29. PubMed ID: 26198591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
